Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Skeletal effects of primary hyperparathyroidism.

Z Syed1, A Khan

  • 1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|January 6, 2001
PubMed
Summary

Primary hyperparathyroidism can lead to bone loss, particularly at cortical sites, though fracture risk findings are conflicting. Medical management and parathyroidectomy show promise for improving bone density.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2001
Same author

Measurement of CP-violating asymmetries in B0 decays to CP eigenstates.

Physical review letters·2001
Same author

The placebo enigma in antidepressant clinical trials.

Journal of clinical psychopharmacology·2001
Same author

Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.

Diabetes·2001
Same author

Hyperglycemia contributes to impaired insulin response in GK rat islets.

Diabetes·2001
Same author

O2 dependence of K+ transport in sickle cells: the effect of different cell populations and the substituted benzaldehyde 12C79.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001

Area of Science:

  • Endocrinology
  • Metabolic Bone Disease

Background:

  • Primary hyperparathyroidism (PHPT) is a common endocrine disorder.
  • It can affect bone mass and fracture risk.
  • Advances in medical management offer new treatment avenues.

Purpose of the Study:

  • To review the impact of PHPT on bone mass and fractures.
  • To explore advances in the medical management of PHPT.

Main Methods:

  • MEDLINE search of publications from 1960-1999.
  • Evaluation of studies on bone mass and fracture risk in PHPT.
  • Review of interventions including hormone therapy, bisphosphonates, calcimimetics, and surgery.

Main Results:

  • Studies indicate preferential bone loss at cortical skeletal sites in PHPT.

Related Experiment Videos

  • Fracture incidence data is conflicting due to study design limitations.
  • Parathyroidectomy and hormone replacement therapy improve bone mineral density.
  • Bisphosphonates and calcimimetic agents show potential for managing PHPT.

    • Conclusions:

    • PHPT is associated with bone loss, especially at cortical sites.
    • Medical management of asymptomatic PHPT appears safe.
    • Bone densitometry is recommended for monitoring bone mass in PHPT patients.